Therapeutic effect of topical administration of SN50, an inhibitor of nuclear factor-kappaB, in treatment of corneal alkali burns in mice.

MLA

Saika, Shizuya, et al. “Therapeutic Effect of Topical Administration of SN50, an Inhibitor of Nuclear Factor-KappaB, in Treatment of Corneal Alkali Burns in Mice.” The American Journal of Pathology, vol. 166, no. 5, May 2005, pp. 1393–403. EBSCOhost, https://doi.org/10.1016/s0002-9440(10)62357-7.

APA

Saika, S., Miyamoto, T., Yamanaka, O., Kato, T., Ohnishi, Y., Flanders, K. C., Ikeda, K., Nakajima, Y., Kao, W. W.-Y., Sato, M., Muragaki, Y., & Ooshima, A. (2005). Therapeutic effect of topical administration of SN50, an inhibitor of nuclear factor-kappaB, in treatment of corneal alkali burns in mice. The American Journal of Pathology, 166(5), 1393–1403. https://doi.org/10.1016/s0002-9440(10)62357-7

Chicago

Saika, Shizuya, Takeshi Miyamoto, Osamu Yamanaka, Tadashi Kato, Yoshitaka Ohnishi, Kathleen C Flanders, Kazuo Ikeda, et al. 2005. “Therapeutic Effect of Topical Administration of SN50, an Inhibitor of Nuclear Factor-KappaB, in Treatment of Corneal Alkali Burns in Mice.” The American Journal of Pathology 166 (5): 1393–1403. doi:10.1016/s0002-9440(10)62357-7.